ABBV vs RVTY: fair value comparison
AbbVie Inc. and Revvity, Inc. · Updated 2026-09-12
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, ABBV currently sits closer to the top of our discount ranking.
| ABBV | RVTY | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $257.12 | $124.31 |
| 12-month range | $206.60–$259.99 | $86.68–$126.59 |
| Sector rank | #86 of 113 Healthcare | #87 of 113 Healthcare |
| Quality grade | B | B |
| Leverage | Low | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Undervalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: ABBV fair value analysis · RVTY fair value analysis